Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/118444
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Walendy, Victor | - |
dc.contributor.author | Stang, Andreas | - |
dc.contributor.author | Girndt, Matthias | - |
dc.date.accessioned | 2025-03-05T07:17:40Z | - |
dc.date.available | 2025-03-05T07:17:40Z | - |
dc.date.issued | 2025 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/120403 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/118444 | - |
dc.description.abstract | Background: Managing acute myocardial infarction (AMI) in patients with chronic kidney disease (CKD) or end-stage renal disease on dialysis (renal replacement therapy, RRT) presents challenges due to elevated complication risks. Concerns about contrast-related kidney damage may lead to the omission of guideline-directed therapies like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in this population. Methods: We analysed German-DRG data of 2016 provided by the German Federal Bureau of Statistics (DESTATIS). We included cases with a primary diagnosis of AMI (ST-Elevation Myocardial Infarction (STEMI) or Non-ST-Elevation Myocardial Infarction (NSTEMI) ICD-10: I21 or I22) with and without CKD or RRT. We calculated crude- and age-standardized hospitalization rates (ASR, per 100,000 person years). Furthermore, we calculated log-binominal regression models adjusting for sex, CKD, RRT, comorbidities, and place of residence to estimate adjusted relative-risks (aRR) for receiving treatments of interest in AMI, such as PCI or CABG. Results: We identified 217,514 AMI-cases (69,728 STEMI-cases and 147,786 NSTEMI-cases). AMI-cases without CKD had percutaneous coronary intervention (PCI) in 60.8%. In contrast, AMI-cases with CKD or RRT had PCI in 46.6% and 54.5%, respectively. The ASR for AMI-cases amounted to 184.7 (95%CI 183.5-185.8) per 100,000 person years. In regression analysis AMI-cases with CKD were less likely treated with PCI (aRR: 0.89 (95%CI 0.88–0.90)), compared to cases without CKD. AMI-Cases with RRT showed no difference in PCI rates (aRR: 1.0 (95%CI 0.97–1.03)) but were more frequently treated with CABG (aRR: 2.20 (95%CI 2.03–2.39)). Conversely, CKD was negatively associated with CABG (aRR: 0.71, 95%CI 0.67–0.75) when non-CKD cases were used as the reference group. Conclusion: We show that AMI-cases with CKD underwent PCI less frequently, while RRT has no discernible impact on PCI utilization in AMI. Furthermore, AMI-cases with RRT exhibited a higher CABG rate. | eng |
dc.language.iso | eng | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject.ddc | 610 | - |
dc.title | Management of acute myocardial infarction in chronic kidney disease in Germany : an observational study | eng |
dc.type | Article | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | BMC nephrology | - |
local.bibliographicCitation.volume | 26 | - |
local.bibliographicCitation.issue | 1 | - |
local.bibliographicCitation.publishername | BioMed Central | - |
local.bibliographicCitation.publisherplace | London | - |
local.bibliographicCitation.doi | 10.1186/s12882-025-03943-5 | - |
local.openaccess | true | - |
dc.identifier.ppn | 1916755828 | - |
cbs.publication.displayform | 2025 | - |
local.bibliographicCitation.year | 2025 | - |
cbs.sru.importDate | 2025-03-05T07:16:48Z | - |
local.bibliographicCitation | Enthalten in BMC nephrology - London : BioMed Central, 2000 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
s12882-025-03943-5.pdf | 1.31 MB | Adobe PDF | ![]() View/Open |